Related Experiment Videos
New concepts in the treatment of elderly hypertensive patients
1Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska Hospital, University of Göteborg, Sweden.
Insights
Initiating antihypertensive treatment with metoprolol, a cardioselective beta-blocker, offers superior prevention of cardiovascular events and mortality compared to diuretics. This approach is effective and safe for elderly patients, improving heart function and reducing arterial stiffness.
Area of Science:
- Cardiology
- Pharmacology
- Geriatrics
Background:
- Antihypertensive therapy is crucial for preventing cardiovascular mortality and atherosclerotic complications, especially in aging populations.
- Elderly hypertensive patients often present with unique physiological challenges, including stiff hearts and isolated systolic hypertension.
- Diuretics have been a traditional first-line treatment, but newer evidence suggests alternative approaches may offer better outcomes.
Purpose of the Study:
- To evaluate the efficacy and safety of initiating antihypertensive treatment with metoprolol in elderly patients.
- To compare the preventive effects of cardioselective beta-blockers versus diuretics on mortality and atherosclerotic complications.
- To explore the mechanisms by which metoprolol improves cardiovascular function in the elderly.
Main Methods:
- Analysis of evidence from secondary and primary prevention trials.
- Inclusion of results from a large-scale, multicenter international study on metoprolol initiation in elderly hypertensive patients.
- Assessment of metoprolol's effects on heart rate, diastolic filling, stroke volume, coronary flow, and arterial stiffness.
Main Results:
- Initiating antihypertensive treatment with metoprolol demonstrates a better preventive effect on total and cardiovascular mortality than diuretics.
- Metoprolol is effective, safe, and well-tolerated as initial therapy in elderly hypertensive patients.
- Long-term metoprolol treatment improves left ventricular compliance, reduces arterial stiffness, and decreases albuminuria.
Conclusions:
- Cardioselective beta-blockers like metoprolol are a preferred initial antihypertensive therapy for elderly patients, offering enhanced cardiovascular protection.
- Metoprolol's benefits extend beyond blood pressure reduction, positively impacting cardiac function and vascular health.
- The findings are particularly relevant for managing isolated systolic hypertension and age-related increases in cardiovascular risk.
Abstract:
Present evidence from several secondary and primary prevention trials indicates that if antihypertensive treatment is initiated with a cardioselective beta-blocker such as metoprolol, a better preventive effect on total mortality, cardiovascular mortality, and atherosclerotic complications can be expected than if diuretics are used as initial therapy. Results from a large-scale, multicenter international study have shown that a regimen in which antihypertensive treatment is initiated with metoprolol once daily is effective, safe, and well tolerated in elderly hypertensive patients. This might be of particular importance since a steep increase in cardiovascular mortality and other atherosclerotic complications is seen with age. In many elderly hypertensive patients, symptoms of heart failure might be caused by poor filling in stiff hearts rather than ineffective systolic contractions. By reducing heart rate with use of a cardioselective beta-blocker, diastole will be prolonged; this will improve filling and hence stroke volume and will increase coronary flow. Long-term treatment with metoprolol has also been found to reduce left ventricular systolic wall stress, reverse hypertrophy, improve left ventricular compliance, decrease the stiffness of large arteries, reduce total peripheral resistance, and reduce albuminuria. The improvement in the stiffness of the large arteries might be of particular clinical importance in elderly patients who have isolated systolic hypertension.